Kenya is strengthening pharmaceutical regulation to ensure patients have access to safe, effective and quality health products distributed through legitimate channels.

At the opening session of the sixth PharmaReg and MedDevReg AfriSummit 2026, Pharmacy and Poisons Board Chairperson Dr John M. Munyu, MBS, said the country has strengthened its laws, technical capacity, quality systems and regulatory processes.

He said Kenya’s journey through the World Health Organization Global Benchmarking Tool has helped make regulatory decisions more consistent, predictable and risk-based.

The five-day Summit was officially opened by Cabinet Secretary for Health Hon. Aden Duale in Nairobi on 28 September 2026, with PPB serving as the official patron.

The Board has introduced the renewal of marketing authorisations, strengthened inspections and enhanced pharmacy practice standards. It is also advancing product authentication, traceability and regulatory reliance to safeguard the pharmaceutical supply chain and enable faster action against substandard and falsified medical products.

Dr Munyu called for stronger collaboration among African regulators, manufacturers and other stakeholders to advance regulatory maturity, local manufacturing, digital systems and supply-chain security.

Held under the theme “Building the Bridge of Health,” the Summit brings together regulators, health professionals, industry representatives and partners from Africa and beyond.

Also present were Principal Secretary for Medical Services Dr Ouma Oluga; AfriSummit Chairperson Dr Mona Moussli; Haleon General Manager for Sub-Saharan Africa Himanshu Raj; PPB Chief Executive Officer Dr Ahmed Mohamed; and Kenya Medical Supplies Authority Chief Executive Officer Dr Waqo Ejersa, among other delegates.

Ends